The FDA agreed that the design of a Phase 3 trial testing privosegtor in optic neuritis could support a future approval ...
As many as 30% of children and teens across the world were nearsighted in 2023, a new study has revealed. Diagnoses of nearsightedness (myopia) are expected to worsen over the next two decades, ...
“An oral drug that improves vision in DME [diabetic macular edema] would be a game changer because it would be more convenient for patients than frequent, often monthly, injections into the eye,” said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results